➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Boehringer Ingelheim
McKesson
Medtronic
AstraZeneca

Last Updated: March 7, 2021

DrugPatentWatch Database Preview

Dopamine hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for dopamine hydrochloride and what is the scope of freedom to operate?

Dopamine hydrochloride is the generic ingredient in six branded drugs marketed by Abbott, Abraxis Pharm, Am Regent, Baxter Hlthcare, Hikma Intl Pharms, Hospira, Igi Labs Inc, Intl Medication, Lyphomed, Smith And Nephew, Teligent, Teva Parenteral, Warner Chilcott, and B Braun, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for dopamine hydrochloride. Seven suppliers are listed for this compound.

Summary for dopamine hydrochloride
US Patents:0
Tradenames:6
Applicants:14
NDAs:37
Drug Master File Entries: 9
Suppliers / Packagers: 7
Bulk Api Vendors: 138
Clinical Trials: 900
Patent Applications: 1,642
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in dopamine hydrochloride?dopamine hydrochloride excipients list
DailyMed Link:dopamine hydrochloride at DailyMed
Recent Clinical Trials for dopamine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sultan Qaboos UniversityPhase 4
Muhimbili University of Health and Allied SciencesPhase 3
International Centre for Diarrhoeal Disease Research, BangladeshPhase 3

See all dopamine hydrochloride clinical trials

Pharmacology for dopamine hydrochloride
Drug ClassCatecholamine
Medical Subject Heading (MeSH) Categories for dopamine hydrochloride

US Patents and Regulatory Information for dopamine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Igi Labs Inc DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 070092-001 Oct 23, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Am Regent DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 070826-001 Feb 11, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Igi Labs Inc DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 070091-001 Oct 23, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
B Braun DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% dopamine hydrochloride INJECTABLE;INJECTION 019099-004 Oct 15, 1986 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Hospira DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dopamine hydrochloride INJECTABLE;INJECTION 018826-001 Sep 30, 1983 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Intl Medication DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 018014-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Johnson and Johnson
Colorcon
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.